Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Developing a machine learning model to map new-build gentrification: A mixed-methods approach.
Journal: PloS one
Published: June 16, 2025
Fragment-based Scaffold Hopping: Identification of Potent, Selective, and Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain (BD2) Inhibitors.
Journal: Journal of medicinal chemistry
Published: July 13, 2021
Insights Into GLP-1 and GIP Actions Emerging From Vildagliptin Mechanism Studies in Man.
Journal: Frontiers in endocrinology
Published: June 28, 2019
Prevalence and epidemiological characteristics of patients with diabetic retinopathy in Slovakia: 12-month results from the DIARET SK study.
Journal: PloS one
Published: May 28, 2019
Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin-metformin combination in newly diagnosed Type 2 diabetes.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: December 18, 2018
Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes Mellitus.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: September 13, 2017
The Vildagliptin Experience - 25 Years Since the Initiation of the Novartis Glucagon-like Peptide-1 Based Therapy Programme and 10 Years Since the First Vildagliptin Registration.
Journal: European endocrinology
Published: May 26, 2017
Clinical Safety and Tolerability of Vildagliptin - Insights from Randomised Trials, Observational Studies and Post-marketing Surveillance.
Journal: European endocrinology
Published: May 26, 2017
DPP-4 inhibitor treatment: β-cell response but not HbA1c reduction is dependent on the duration of diabetes.
Journal: Vascular health and risk management
Published: April 15, 2017
Ultraconfined Plasmonic Hotspots Inside Graphene Nanobubbles.
Journal: Nano letters
Published: December 15, 2016
Blood pressure and fasting lipid changes after 24 weeks' treatment with vildagliptin: a pooled analysis in >2,000 previously drug-naïve patients with type 2 diabetes mellitus.
Journal: Vascular health and risk management
Published: August 31, 2016
Last Updated: 09/26/2026